Skip to main content

Is kidney transplantation in sensitized recipients justified?

  • Conference paper
Transplant International

Abstract

The objective of the study was to determine if it is justified to use the scarce resources of cadaveric kidneys on HLA-sensitized patients, by reviewing the initial and longterm outcome of cadaveric renal transplantation at Uppsala University Hospital, Sweden. Between January 1988 and December 1994, 402 renal transplantations were performed. The patients were divided into one group of sensitized recipients (peak panel antibody reactivity ≥ 25 %; n = 84) and a second of non-sensitized recipients (panel reactive antibodies < 25 %; n = 318). The groups were comparable in terms of recipient and donor age, gender, HLA-A, -B and -DR mismatches and numbers of diabetics. None of the sensitized patients received a six-antigen-matched kidney. For the non-sensitized group, life table analysis showed a 1-year actuarial graft survival (GS) of 91.8 % and a 4-year GS of 84.4 %. The corresponding GSs for the sensitized group were 79.9 % and 68.7 %, respectively (P < 0.01). The statistical significance vanished if patients with primary non-function were excluded. When excluding donors above 55 years of age, kidneys with cold ischemia time above 20 h, and two-antigen (HLA-DR) mismatches, there was no detectable difference between the non-sensitized and sensitized groups at 1-year or 4-year GS. Although there is a statistical significance in GS between non-sensitized and sensitized recipients of a kidney transplant, this does not differ from other risk groups such as diabetics, rheumatoid disease sufferers or elderly recipients. We therefore conclude that the sensitized patient should be accepted on the waiting list for a kidney transplant and that it is worthwhile to do the utmost to transplant this category of patients. Our data indicate that kidney GS in sensitized recipients is more affected by negative risk factors such as older donors, long cold ischemia time and two-antigen HLA-DR mismatch, than the non-sensitized recipient. To improve the outcome, those negative factors should be avoided or reduced.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alarabi AA, Wikström B, Backman U, et al (1993) Pretransplantation immunoadsorption therapy in patients immunized with human lymphocyte antigen. Artif Organs 17: 702–707

    Article  PubMed  CAS  Google Scholar 

  2. Charpentier B, Hiesse C, Faycal K, et al (1992) How to deal with the hyperimmunized potential recipients. Kidney Int Suppl 38: 176–181

    Google Scholar 

  3. Gjertson DW (1993) Center-dependent transplantation factors. Clin Transplant: 445–468

    Google Scholar 

  4. Iwaki Y, Terasaki PI (1987) Primary nonfunction in human cadaver kidney transplantation: evidence for hidden hyperacute rejection. Clin Transpl 1: 125–131

    Google Scholar 

  5. Madsen M, Adsmussen P, Brekke I, et al (1994) Scandiatransplant year book (in press)

    Google Scholar 

  6. Mahoney R (1990) The flow cytometric crossmatch and early renal transplant loss. Transplantation 3: 527–535

    Article  Google Scholar 

  7. Norman DJ (1991) Outcome of renal transplantation at Oregon Health Sciences University. Clin Transplant: 153–157

    Google Scholar 

  8. Ogura K (1992) Sensitization. Clin Transplant: 357–369

    Google Scholar 

  9. Opelz G (1986) Clin Transplant Newslett: June

    Google Scholar 

  10. Rankin GW, Wang XM, Terasaki PI (1990) Sensitization to kidney transplants. Clin Transplant: 417–424

    Google Scholar 

  11. Smit JA, Stark JH, Margolius, et al (1991) The relevance of more sensitive ancillary crossmatch techniques in predicting early cadaver renal graft outcome. Transpl Int 4: 77–81

    PubMed  CAS  Google Scholar 

  12. Terasaki PI, Park MS, Takemoto S, et al (1989) Overview and epitope matching. Clin Transplant: 499–516

    Google Scholar 

  13. Wahlberg J, Bengtsson M, Bergström C, et al (1991) Impact of flow cytometric cross matching on the outcome of cadaveric kidney transplantation. Transpl Proc 26: 1752–1753

    Google Scholar 

  14. Washburn WK, Shaffer D, Conway P, et al (1959) A single-center experience with six-antigen matched kidney transplants. Arch Surg 130: 277–282

    Article  Google Scholar 

  15. Zhou YC, Cecka JM (1991) Sensitization and renal transplantation. Clin Transplant: 313–323

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bersztel, A. et al. (1996). Is kidney transplantation in sensitized recipients justified?. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-00818-8_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61024-3

  • Online ISBN: 978-3-662-00818-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics